Home > Insider Trading > Filing (0001209191-14-061636)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1453943	Thomas Connolly	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-10-01	450	$107.28	15,195	No	4	S	Direct
Common Stock	Disposition	2014-10-01	200	$108.30	14,995	No	4	S	Direct
Common Stock	Disposition	2014-10-01	100	$111.52	14,895	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	150	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $107.28 (range $106.92 to $107.84).
Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $108.30 (range $108.06 to $108.54).